Exicure (XCUR) News Today $18.67 +2.93 (+18.61%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Exicure Names Andy Yoo as President, CEODecember 20 at 10:19 PM | marketwatch.comExicure Shareholders Approve Major HiTron Equity FinancingDecember 20 at 6:07 PM | tipranks.comExicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board ChangesDecember 20 at 4:42 PM | businesswire.comExicure, Inc. (NASDAQ:XCUR) Short Interest Up 479.6% in NovemberDecember 12, 2024 | americanbankingnews.comExicure Inc trading resumesDecember 5, 2024 | markets.businessinsider.comExicure Inc trading halted, volatility trading pauseDecember 5, 2024 | markets.businessinsider.comShort Interest in Exicure, Inc. (NASDAQ:XCUR) Declines By 47.9%Exicure, Inc. (NASDAQ:XCUR - Get Free Report) was the recipient of a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 16,200 shares, a decline of 47.9% from the October 31st total of 31,100 shares. Approximately 2.0% of the shares of the company are sold short. Based on an average trading volume of 1,620,000 shares, the short-interest ratio is presently 0.0 days.November 28, 2024 | marketbeat.comHow Is The Market Feeling About Exicure?November 26, 2024 | benzinga.comExicure Signs Equity-Financing Deals With HiTron SystemsNovember 14, 2024 | marketwatch.comXCUR/USD - Curate US DollarOctober 28, 2024 | investing.com(PNGJL.BO)September 19, 2024 | finance.yahoo.comExicure Shares More Than Double After Nasdaq Listing ExtensionSeptember 18, 2024 | marketwatch.comExicure, Inc. Receives Extension from Nasdaq Hearings PanelSeptember 18, 2024 | finance.yahoo.comExicure, Inc. Receives Extension from Nasdaq Hearings PanelSeptember 18, 2024 | businesswire.comExicure, Inc. (NASDAQ:XCUR) Major Shareholder Co. Ltd. Dgp Buys 237,223 SharesSeptember 17, 2024 | insidertrades.comWhat's Going On With Exicure Shares Monday?September 16, 2024 | msn.comStocks to Watch: Exicure, Volato Group, CanooSeptember 13, 2024 | marketwatch.comExicure Shares Surge 78% on Debt-for-Equity Exchange AgreementsSeptember 13, 2024 | marketwatch.comExicure, Inc. Announces Proposed Settlement of Securities Class Action LitigationSeptember 9, 2024 | tmcnet.comExicure announces reverse stock split to meet Nasdaq rulesAugust 28, 2024 | investing.comExicure, Inc. (2H0A.F)August 28, 2024 | nz.finance.yahoo.comExicure Inc (2H0A.SG)August 27, 2024 | nz.finance.yahoo.comExicure Inc (2H0A.BE)August 27, 2024 | nz.finance.yahoo.comExicure, Inc. Announces 1-for-5 Reverse Stock SplitAugust 26, 2024 | finance.yahoo.comExicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special MeetingAugust 19, 2024 | stockhouse.comExicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special MeetingAugust 15, 2024 | finance.yahoo.comXCUR Stock Earnings: Exicure Reported Results for Q2 2024August 13, 2024 | markets.businessinsider.comExicure, Inc. Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | finance.yahoo.comExicure, Inc. Recruits Head of Corporate Development and BioinformaticsAugust 9, 2024 | stockhouse.comExicure, Inc. (XCUR) latest stock news & headlines – Yahoo FinanceAugust 4, 2024 | au.finance.yahoo.comExicure, Inc. Receives Positive Listing Determination from NasdaqAugust 1, 2024 | businesswire.comWhy Is Exicure (XCUR) Stock Down 27% Today?July 22, 2024 | investorplace.comXCUR Stock Earnings: Exicure Reported Results for Q1 2024June 17, 2024 | investorplace.comExicure, Inc. Reports First Quarter 2024 Financial ResultsJune 17, 2024 | businesswire.comXCUR Stock Earnings: Exicure Reported Results for Q4 2023June 6, 2024 | investorplace.comWhy Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving PremarketMay 29, 2024 | msn.comExicure, Inc. Received Nasdaq Notice of a Delisting DeterminationMay 23, 2024 | finance.yahoo.comExicure, Inc. Received Nasdaq Notice of a Delisting DeterminationMay 23, 2024 | businesswire.comExicure, Inc. (XCUR)May 18, 2024 | finance.yahoo.comXCUR Stock Earnings: Exicure Reported Results for Q3 2023May 16, 2024 | investorplace.comExicure, Inc. Reports Third Quarter 2023 Financial ResultsMay 16, 2024 | finance.yahoo.comExicure, Inc. Reports Third Quarter 2023 Financial ResultsMay 16, 2024 | businesswire.comExicure faces Nasdaq non-compliance over delayed filingApril 24, 2024 | investing.comExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-KApril 22, 2024 | businesswire.comExicure Stock (NASDAQ:XCUR), Short Interest ReportFebruary 22, 2024 | benzinga.comWhy FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionFebruary 6, 2024 | benzinga.comWhy Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving PremarketFebruary 6, 2024 | msn.comExicure Inc Announces Licensing Patents for Therapeutic AdvancementFebruary 6, 2024 | msn.comExicure, Bluejay Therapeutics Enter Patent License Agreement to Develop Hepatitis TreatmentFebruary 5, 2024 | marketwatch.comExicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of HepatitisFebruary 5, 2024 | finance.yahoo.com Get Exicure News Delivered to You Automatically Sign up to receive the latest news and ratings for XCUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover XCUR Media Mentions By Week XCUR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XCUR News Sentiment▼0.300.60▲Average Medical News Sentiment XCUR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XCUR Articles This Week▼31▲XCUR Articles Average Week Get Exicure News Delivered to You Automatically Sign up to receive the latest news and ratings for XCUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Opthea News Solid Biosciences News Kyverna Therapeutics News Gossamer Bio News MediWound News Bright Minds Biosciences News TuHURA Biosciences News Innate Pharma News Corbus Pharmaceuticals News Sagimet Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XCUR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exicure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exicure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XCUR Stock Alerts